Hostname: page-component-745bb68f8f-hvd4g Total loading time: 0 Render date: 2025-02-11T07:57:18.660Z Has data issue: false hasContentIssue false
  • English
  • Français

“Temposil” A New Drug in the Treatment of Alcoholism

Published online by Cambridge University Press:  08 February 2018

Alfred Minto  and
F. J. Roberts
Alfred Minto
Affiliation:
Mapperley Hospital, Nottingham
F. J. Roberts
Affiliation:
From the Alcoholic Unit, St. Luke's Hospital, Middlesbrough
Rights & Permissions [Opens in a new window]

Extract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

In the last decade the use of disulfiram (Antabuse) has considerably altered the treatment of chronic alcoholism. However, unpleasant side-effects of headache, metallic taste in the mouth, abdominal discomfort and impotence are found in patients on maintenance treatment with this drug and deters them from taking it (4, 10). Alcohol-disulfiram reactions can be accompanied by cardiac complications or sudden death (9, 11). Despite these difficulties alcoholics who take disulfiram regularly have better abstinence records than those who do not (15). Many reasons may be postulated for these results, but we have regarded the use of disulfiram as a means of providing a period of “forced” abstinence while the alcoholic is readjusting to the demands of resuming his job, family relations, etc. During this time some insight and understanding of the nature of his difficulties may be established. The remainder of this paper describes the investigation of a new substance, Temposil, which produces a similar effect to disulfiram.

Type
Original Articles
Information
Journal of Mental Science , Volume 106 , Issue 442 , January 1960 , pp. 288 - 295
Copyright
Copyright © Royal College of Psychiatrists, 1960 

References

1. Armstrong, J. D., and Kerr, H. T., J. Can. Med. Ass., 1956, 74, 795–797.Google Scholar
2. Bell, R. G., J. Can. Med. Ass., 1956, 74, 797–798.Google Scholar
3. Divatia, K. J., Hine, C. H., and Burbridge, T. N., J. Lab. and Clin. Med., 1952, 39, 974.Google Scholar
4. Feldman, D. J., and Zucker, H. D., J.A.M.A., 1953, 153, 895.Google Scholar
5. Ferguson, J. K. W., J. Can. Med. Ass., 1956, 74, 793–795.Google Scholar
6. Idem , Maharajh, M., and Warson, M. S., J. Pharmocol. and Exper. Therapy, 1955, 113, 20.Google Scholar
7. Graham, W. D., J. Pharm. and Pharmocol., 1951, 3, 160.Google Scholar
8. Hine, C. H., J. Clin. Invest., 1952, 31, 317.CrossRefGoogle Scholar
9. Jacobsen, E., Quart. J. Stud. Alcohol., 1952, 13, 16.Google Scholar
10. MacDonald, J. M., and Ebaugh, F. G., M. Clin. North America, 1954, 38, 515.Google Scholar
11. Macklin, E. A., J.A.M.A., 1951, 146, 1377.Google Scholar
12. Raby, K., Quart. J. Stud. Alcohol, 1954, 15, 21.Google Scholar
13. Skelton, F. R., McConkey, H. M., and Grant, G., Canad. J. M. Sc., 1952, 30, 151.Google Scholar
14. Smith, J. A., Wolford, J. A., Weber, M., and McLean, D., Paper read at meeting of A.M.A., June, 1957. New York.Google Scholar
15. Wallerstein, R. S., Hospital Treatment of Alcoholism, 1957. London.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.